Key result
Female sex was associated with significantly better 3-year survival compared to male sex after transcatheter edge-to-edge repair for mitral regurgitation (60.7% vs. 54.2%; HR 0.8, 95% CI 0.6-0.9).
Why the study?
Sex differences in outcomes are evident after surgical mitral regurgitation treatment, but data regarding sex-specific outcomes following transcatheter edge-to-edge repair remain limited and conflicting.
Does female sex impact procedural safety, efficacy, and long-term survival compared to male sex in patients undergoing transcatheter edge-to-edge repair for mitral regurgitation?
Population
821 patients undergoing TEER for mitral regurgitation
Comparison
Female vs male patients
Design
Multicenter observational cohort study
Follow-up
3 years
Authors
Loading...
Women show similar TEER safety but better adjusted long-term survival than men; observational data leave open whether sex- or AF-tailored strategies are needed.
Cohort (n=821)
Yes
Does female sex impact procedural safety, efficacy, and long-term survival compared to male sex in patients undergoing transcatheter edge-to-edge repair for mitral regurgitation?
Hazard Ratio: 0.8 (95% CI 0.6–0.9)
Absolute Event Rate: 60.7% vs 54.2%
p-value: p=0.02
Female patients undergoing TEER for mitral regurgitation exhibit better long-term survival than males, although concomitant atrial fibrillation negates this survival advantage.
Ausbuettel et al. (2023) conducted a cohort in Mitral regurgitation (n=821). Female sex vs. Male sex was evaluated on All-cause death at 3 years (HR 0.8, 95% CI 0.6-0.9, p=0.02). Female sex was associated with significantly better 3-year survival compared to male sex after transcatheter edge-to-edge repair for mitral regurgitation (60.7% vs. 54.2%; HR 0.8, 95% CI 0.6-0.9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: